All patients and healthy controls have completed the study
At the end of August 2022, our last participant successfully completed the study. We reached our goal of recruiting 48 participants and achieved a participation rate of 92%. We thank all patients and control persons for their commitment, curiosity and assistance and wish them all the best for the future. In a next step, we will focus on the data analysis of the biometric and clinical data of the participats.